Intézmény

Hammersmith Hospital

London, Egyesült KirályságHonlap

Más néven: Military Orthopaedic Hospital

71futó vizsgálat
24lezárt vizsgálat

Futó vizsgálatok

Toboroz
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
NCT07648264· 3. fázis· CSL Behring· Forrás
Toboroz
A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis
NCT07422532· Imperial College London· Forrás
Toboroz
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465· 3. fázis· Kardigan, Inc.· Forrás
Toboroz
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
NCT07291076· 1/2. fázis· Bristol-Myers Squibb· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723· 2/3. fázis· Kardigan, Inc.· Forrás
Toboroz
Prospective Evaluation of AI-ECG for SHD Detection
NCT07057466· Imperial College London· Forrás
Toboroz
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
NCT06989437· 2/3. fázis· Pfizer· Forrás
Toboroz
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013· 1/2. fázis· Eli Lilly and Company· Forrás
Toboroz
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
NCT06892522· 1/2. fázis· AbbVie· Forrás
Toboroz
A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
NCT06786234· 2. fázis· Step Pharma, SAS· Forrás
Toboroz
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
NCT06925750· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Fut, nem toboroz
Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
NCT06814145· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
NCT06890884· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT06588478· 2. fázis· Loxo Oncology, Inc.· Forrás
Fut, nem toboroz
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
NCT06578247· 3. fázis· Daiichi Sankyo· Forrás
Toboroz
Remote Cardiovascular Monitoring in Post-TAVI Patients
NCT06602609· Imperial College London· Forrás
Fut, nem toboroz
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
NCT06500884· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Personalized Medicine for Advanced Biliary Cancer Patients
NCT05615818· 3. fázis· UNICANCER· Forrás
Fut, nem toboroz
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Fut, nem toboroz
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT06425991· 1. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
NCT06226571· 1. fázis· Syndax Pharmaceuticals· Forrás
Toboroz
Ablation of Focal Activation in Atrial Fibrillation
NCT06402617· Imperial College London· Forrás
Fut, nem toboroz
Differentiation of Benign From Malignant Thyroid Nodules Using Diffuse Reflectance Spectroscopy
NCT07124065· Imperial College London· Forrás
Fut, nem toboroz
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
NCT06191744· 3. fázis· Genmab· Forrás
Fut, nem toboroz
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
NCT06132958· 3. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
NCT05730036· 3. fázis· Regeneron Pharmaceuticals· Forrás
Fut, nem toboroz
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)
NCT05904886· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
NCT06052475· Imperial College London· Forrás
Toboroz
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
NCT05967143· Sirtex Medical· Forrás
Fut, nem toboroz
Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease
NCT05755711· Shockwave Medical, Inc.· Forrás
Toboroz
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924· 1/2. fázis· Institut de Recherches Internationales Servier· Forrás
Fut, nem toboroz
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
NCT05612035· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
The Role of Right Atrial Ectopy Triggering Ganglionated Plexuses in AF
NCT05539040· Imperial College London· Forrás
Fut, nem toboroz
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
NCT05578976· 3. fázis· Genmab· Forrás
Meghívásos bevonás
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
NCT05768386· 4. fázis· BioMarin Pharmaceutical· Forrás
Fut, nem toboroz
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
NCT05531526· 3. fázis· AriBio Co., Ltd.· Forrás
Toboroz
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
NCT03994471· 3. fázis· Iperboreal Pharma Srl· Forrás
Fut, nem toboroz
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
NCT05455320· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
NCT05456685· 2. fázis· AbbVie· Forrás
Toboroz
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
NCT05431088· 2/3. fázis· Pfizer· Forrás
Toboroz
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085· 3. fázis· Celgene· Forrás
Toboroz
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
NCT05185739· 2. fázis· University College, London· Forrás
Toboroz
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171· 2/3. fázis· Panbela Therapeutics, Inc.· Forrás
Toboroz
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT05487612· Aristotle University Of Thessaloniki· Forrás
Toboroz
Lutathera and ASTX727 in Neuroendocrine Tumours
NCT05178693· 1. fázis· Imperial College London· Forrás
Toboroz
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
NCT04493632· OncoSil Medical Limited· Forrás

Showing 50 of 71.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Mielóma multiplex5 toboroz
Máj- és epeúti rák4 toboroz
2-es típusú cukorbetegség3 toboroz
Hasnyálmirigyrák3 toboroz
Krónikus limfoid leukémia (CLL)3 toboroz
Mieloproliferatív neopláziák3 toboroz
Akut limfoid leukémia (ALL)2 toboroz
Dilated cardiomyopathy2 toboroz
Elhízás2 toboroz
Krónikus vesebetegség2 toboroz
Magas vérnyomás2 toboroz
Pitvarfibrilláció2 toboroz
Pulmonális artériás hipertónia2 toboroz
Sarlósejtes vérszegénység2 toboroz
Szívelégtelenség2 toboroz
Vastagbélrák2 toboroz
Akut mieloid leukémia (AML)1 toboroz
Aortic stenosis1 toboroz
Asztma1 toboroz
Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
Gyermekkori daganatok1 toboroz
Hemofília1 toboroz
Hodgkin-limfóma1 toboroz
Immune thrombocytopenia (ITP)1 toboroz
Krónikus mieloid leukémia (CML)1 toboroz
Méhtestrák1 toboroz
Mielodiszplasztikus szindróma (MDS)1 toboroz
Neuroendokrin daganatok1 toboroz
Pajzsmirigyrák1 toboroz
Thalassaemia1 toboroz
Tüdőrák1 toboroz

Lezárt vizsgálatok

Lezárult
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)
NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás
Toboroz
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
NCT06274801· 3. fázis· Gossamer Bio USA, Inc.· Forrás
Lezárult
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
NCT05934526· 3. fázis· GB002, Inc.· Forrás
Leállították
A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
NCT06039384· 1. fázis· Incyte Corporation· Forrás
Lezárult
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
NCT06137742· 1/2. fázis· Pfizer· Forrás
Lezárult
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.
NCT05844566· Imperial College London· Forrás
Lezárult
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
NCT05507203· 3. fázis· Abivax S.A.· Forrás
Lezárult
A Study to Test Whether Different Combinations of BI 765063, Ezabenlimab, Chemotherapy, Cetuximab, and BI 836880 Help People With Head and Neck Cancer or Liver Cancer
NCT05249426· 1. fázis· Boehringer Ingelheim· Forrás
Lezárult
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
NCT04987489· 2. fázis· Forma Therapeutics, Inc.· Forrás
Lezárult
A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).
NCT04912869· 1. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)
NCT05075824· 2. fázis· Hoffmann-La Roche· Forrás
Leállították
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
NCT05070845· 2. fázis· Pfizer· Forrás
Lezárult
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
NCT05091346· 1/2. fázis· Eisai Inc.· Forrás
Leállították
The Long-term Safety and Effect of Renal Denervation
NCT05818813· Imperial College Healthcare NHS Trust· Forrás
Leállították
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
NCT04271475· 3. fázis· Actelion· Forrás
Lezárult
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
NCT03982394· AbbVie· Forrás
Lezárult
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
NCT04173533· 3. fázis· University of Birmingham· Forrás
Lezárult
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
NCT03782207· Hoffmann-La Roche· Forrás
Lezárult
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
NCT03594110· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Long Term Extension Trial of Setmelanotide
NCT03651765· 2/3. fázis· Rhythm Pharmaceuticals, Inc.· Forrás
Lezárult
Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
NCT03117933· 2. fázis· University of Oxford· Forrás
Leállították
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
NCT02629692· 1/2. fázis· Sun Pharma Advanced Research Company Limited· Forrás
Lezárult
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer
NCT02101788· 2/3. fázis· National Cancer Institute (NCI)· Forrás

Regiszterbeli névváltozatok (24)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

Hammersmith Hospital
London, W12 0HS
66 vizsgálat
Hammersmith Hospital London
London, W2 1NY
3 vizsgálat
- NCT04987489A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
- NCT04624659A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
- NCT02170090Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
Imperial College London - Hammersmith Hospital
London, SW7 2AZ
3 vizsgálat
- NCT06786234A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
  Contact: Carol M MacLean, PhD
- NCT05091346A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
- NCT02649426A Study of the ReCor Medical Paradise System in Clinical Hypertension
Hammersmith Hospital, Imperial College of London
London, W12 0HS
2 vizsgálat
- NCT07771465A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
- NCT07210723A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
Hammersmith Hospital (Site 1801)
London, London, City of W12 OHS
2 vizsgálat
- NCT06925750A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)
- NCT06664801A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)
Department of Cardiothoracic Surgery, Hammersmith Hospital
London, W120HS
1 vizsgálat
- NCT05487612MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
  Contact: Georgios Papazisis, Assoc. Prof.
Hammersmith Hospital
Acton, London W12 0HS
1 vizsgálat
- NCT02711553A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
Hammersmith Hospital, Clinical Research Facility, Centre for Translational and Experimental Medicine
London
1 vizsgálat
- NCT05768386A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Hammersmith Hospital-Department of Cardiology (Site 0900)
London, London, City of W12 OHS
1 vizsgálat
- NCT06814145Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Hammersmith Hospital-Department of Cardiology (Site 2401)
London, London, City of W12 OHS
1 vizsgálat
- NCT05612035Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
Hammersmith Hospital - Haematology Dept
London
1 vizsgálat
- NCT04208529A Long-term Follow-up Study in Participants Who Received CTX001
Hammersmith Hospital /ID# 171446
London, England W12 0HS
1 vizsgálat
- NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
Hammersmith Hospital /ID# 215978
London, England W12 0HS
1 vizsgálat
- NCT03982394Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
Hammersmith Hospital /ID# 242215
London, England W12 0HS
1 vizsgálat
- NCT05578976A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Hammersmith Hospital /ID# 261124
London, England W12 0HS
1 vizsgálat
- NCT06191744Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Hammersmith Hospital /ID# 268945
London, England W12 0HS
1 vizsgálat
- NCT05456685Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
Hammersmith Hospital /ID# 274615
London, England W12 0HS
1 vizsgálat
- NCT06892522A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Hammersmith Hospital (Site 0533)
London, London, City of W12 OHS
1 vizsgálat
- NCT06456346Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Hammersmith Hospital (Site 0915)
London, London, City of W12 0 HS
1 vizsgálat
- NCT06890884A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
  Contact: Study Coordinator
Hammersmith Hospital (Site 1203)
London, London, City of W12 0HS
1 vizsgálat
- NCT07218029A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Hammersmith Hospital (Site 4001)
London, London, City of W12 OHS
1 vizsgálat
- NCT06132958Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)
Hammersmith Hospital (Site 4010)
London, London, City of W12 0HS
1 vizsgálat
- NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
  Contact: Study Coordinator
Imperial College London, Hammersmith Hospital, Surgery&Cancer
London, W12 OHS
1 vizsgálat
- NCT02828618Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NIHR/Wellcome Trust Imperial CRF, Hammersmith Hospital
London, Greater London
1 vizsgálat
- NCT01945840Gut Hormones and Roux en Y Gastric Bypass
  Contact: Stephen R Bloom, PhD (principal investigator)

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Pulmonális artériás hipertónia20 munka · 11 vizsgálat
Immune thrombocytopenia (ITP)5 munka · 2 vizsgálat
Krónikus mieloid leukémia (CML)5 munka · 2 vizsgálat

Intézményadatok: ROR 05jg8yp15 (CC0-1.0)Frissítve: 2026. nov. 12.

Hibát jelzek